TR199903297T2 - ��z�lm�� sertralin bile�imleri. - Google Patents

��z�lm�� sertralin bile�imleri.

Info

Publication number
TR199903297T2
TR199903297T2 TR1999/03297T TR9903297T TR199903297T2 TR 199903297 T2 TR199903297 T2 TR 199903297T2 TR 1999/03297 T TR1999/03297 T TR 1999/03297T TR 9903297 T TR9903297 T TR 9903297T TR 199903297 T2 TR199903297 T2 TR 199903297T2
Authority
TR
Turkey
Prior art keywords
sertraline
imleri
enhances
solubility
solvent
Prior art date
Application number
TR1999/03297T
Other languages
English (en)
Turkish (tr)
Inventor
Thomas Friesen Dwayne
Max Herbig Scott
Mysore Shanker Ravi
Blair West James
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199903297(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR199903297T2 publication Critical patent/TR199903297T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR1999/03297T 1997-07-01 1998-06-15 ��z�lm�� sertralin bile�imleri. TR199903297T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
TR199903297T2 true TR199903297T2 (xx) 2000-07-21

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03297T TR199903297T2 (xx) 1997-07-01 1998-06-15 ��z�lm�� sertralin bile�imleri.

Country Status (34)

Country Link
EP (1) EP0999829A1 (no)
JP (1) JP2000514100A (no)
KR (1) KR100366373B1 (no)
CN (1) CN1261794A (no)
AP (1) AP1192A (no)
AR (3) AR015917A1 (no)
AU (1) AU742535B2 (no)
BG (1) BG103918A (no)
BR (1) BR9810739A (no)
CA (1) CA2290974C (no)
CO (1) CO4940495A1 (no)
DZ (1) DZ2548A1 (no)
EA (1) EA002481B1 (no)
HN (1) HN1998000102A (no)
HR (1) HRP980377A2 (no)
HU (1) HUP0002236A3 (no)
ID (1) ID23429A (no)
IL (1) IL133076A (no)
IS (1) IS5260A (no)
MA (1) MA24587A1 (no)
NO (1) NO996520L (no)
OA (1) OA11243A (no)
PA (1) PA8454301A1 (no)
PE (1) PE97199A1 (no)
PL (1) PL337804A1 (no)
SK (1) SK181099A3 (no)
TN (1) TNSN98124A1 (no)
TR (1) TR199903297T2 (no)
TW (1) TW550087B (no)
UA (1) UA67741C2 (no)
UY (1) UY25071A1 (no)
WO (1) WO1999001120A1 (no)
YU (1) YU68299A (no)
ZA (1) ZA985708B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20053427B (en) 1999-12-23 2005-01-25 Pfizer Prod Inc Pharmaceutical Compositions Providing Enhanced Drug Concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
MXPA03001771A (es) 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
JPWO2011081117A1 (ja) * 2009-12-29 2013-05-09 興和株式会社 経口投与用固形医薬組成物
CN102711763A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用医药组合物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (de) * 1989-08-30 1993-11-15 Pfizer Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
WO1999001120A1 (en) 1999-01-14
MA24587A1 (fr) 1998-12-31
HN1998000102A (es) 1999-01-08
BG103918A (en) 2000-07-31
HRP980377A2 (en) 1999-04-30
AR015917A1 (es) 2001-05-30
IS5260A (is) 1999-11-19
ZA985708B (en) 2000-01-10
BR9810739A (pt) 2000-09-12
AP1192A (en) 2003-07-23
NO996520L (no) 2000-02-29
UA67741C2 (uk) 2004-07-15
HUP0002236A2 (hu) 2003-08-28
SK181099A3 (en) 2000-07-11
OA11243A (en) 2003-07-24
PA8454301A1 (es) 2000-09-29
EA199900962A1 (ru) 2000-08-28
EA002481B1 (ru) 2002-06-27
AR040280A2 (es) 2005-03-23
AP9801280A0 (en) 1998-06-30
CN1261794A (zh) 2000-08-02
JP2000514100A (ja) 2000-10-24
IL133076A (en) 2003-12-10
AR040279A2 (es) 2005-03-23
AU7544898A (en) 1999-01-25
DZ2548A1 (fr) 2003-02-08
UY25071A1 (es) 2000-12-29
PE97199A1 (es) 1999-10-05
CO4940495A1 (es) 2000-07-24
PL337804A1 (en) 2000-09-11
CA2290974C (en) 2004-04-27
NO996520D0 (no) 1999-12-28
AU742535B2 (en) 2002-01-03
ID23429A (id) 2000-04-20
HUP0002236A3 (en) 2003-12-29
IL133076A0 (en) 2001-03-19
CA2290974A1 (en) 1999-01-14
KR100366373B1 (ko) 2003-01-14
TNSN98124A1 (fr) 2005-03-15
TW550087B (en) 2003-09-01
EP0999829A1 (en) 2000-05-17
YU68299A (sh) 2002-06-19
KR20010013365A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
DE69837176D1 (de) Datenkartengehäuse
NO996269D0 (no) Quinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
DE3852292D1 (de) Sicherheitswegmechanismus für virtuelle Terminalumgebungen.
DE69109590D1 (de) Kompressorgehäuse-Konstruktion.
ID22008A (id) Peralatan panggembung ganda yang mencakup penggembung piroteknik
TR199903297T2 (xx) ��z�lm�� sertralin bile�imleri.
BR0103824A (pt) Vernizes em pó de pur foscos
DE69019468D1 (de) In der Decke integrierte Gehäuse.
NO894471D0 (no) Anti-statiske polyuretan-urea-dispersjoner.
DE69100676D1 (de) Elektrochemischer Ionenaustausch.
DE69800656T2 (de) Stabiles Gehäuse für tragbare Vorrichtungen
DE69803898D1 (de) Kassette aufnehmendes Gehäuse
ES2135535T3 (es) Derivados tiazolotriazol y tiazolodiazol con actividad fungicida.
BR9805016B1 (pt) cartucho de processamento eletrostatográfico.
ATE296493T1 (de) Gehäuse
ES2106543T3 (es) Dispositivo de deteccion.
ITMI932626A0 (it) Contatore con alloggiamento incorporato di batterie e di elemento elettroluminescente.
ES1025392Y (es) Linterna autoadhesiva.
KR970061071U (ko) 스티커식 명함지
TR199801094U (xx) Geliştirilmiş bağlayıcı bant sistemi
ITTO910015U1 (it) Corredo antifuoco.
TR200003234T2 (tr) N-Hidroksiasetanilit gibi hızlandırıcılar.
KR900011861U (ko) 두루마리형 스티커(sticker)합착기
NO895274D0 (no) Baerbar elektronisk ionetransportoer.
ES1013306Y (es) Respaldo portatil.